Literature DB >> 24919481

Risk for nevus transformation and melanoma proliferation and invasion during natalizumab treatment: four years of dermoscopic follow-up with immunohistological studies and proliferation and invasion assays.

Momen Pharaon1, Mélanie Tichet2, Christine Lebrun-Frénay3, Sophie Tartare-Deckert2, Thierry Passeron4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24919481     DOI： 10.1001/jamadermatol.2013.9411

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  3 in total

Review 1.  Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR).

Authors:  Rachel A Sabol; Virginia Noxon; Oliver Sartor; Joseph R Berger; Zaina Qureshi; Dennis W Raisch; LeAnn B Norris; Paul R Yarnold; Peter Georgantopoulos; William J Hrushesky; Laura Bobolts; Paul Ray; Akida Lebby; Robert C Kane; Charles L Bennett
Journal:  Cancer Med       Date:  2017-06-20       Impact factor: 4.452

2.  Glioblastoma in natalizumab-treated multiple sclerosis patients.

Authors:  Fabian Sierra Morales; Robert B Wright; Jorge E Novo; Leonidas D Arvanitis; Dusan Stefoski; Igor J Koralnik
Journal:  Ann Clin Transl Neurol       Date:  2017-06-06       Impact factor: 4.511

3.  Multiple Sclerosis Treatment and Melanoma Development.

Authors:  Maria Luigia Carbone; Pedro Miguel Lacal; Serena Messinese; Laura De Giglio; Carlo Pozzilli; Severino Persechino; Cinzia Mazzanti; Cristina Maria Failla; Gianluca Pagnanelli
Journal:  Int J Mol Sci       Date:  2020-04-22       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.